<p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) 的股東們會很高興地看到，股價在過去一個月表現出色，上漲了 38%，並從之前的疲軟中恢復過來。上個月的表現為過去一年 103% 的大幅增長畫上了句號。</p>
<p>在價格大幅反彈後，EyePoint 的市銷率（&#34;P/S&#34;）為 31.5 倍，與美國製藥行業的其他公司相比，可能看起來像是一個強烈的賣出信號，因為大約一半的公司市銷率低於 4.1 倍，甚至低於 1.3 倍的市銷率也相當普遍。不過，僅僅將市銷率表面化是不明智的，因為可能有解釋説明其如此高的原因。</p>
<p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
<p>查看我們對 EyePoint 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809"/></p>
<p>NasdaqGM:EYPT 市銷率與行業比較 2025 年 12 月 12 日</p>
<h3>EyePoint 的市銷率對股東意味着什麼？</h3>
<p>最近，EyePoint 的表現不佳，其收入下降與其他公司相比顯得相當糟糕，後者的收入平均有所增長。一個可能性是，市銷率之所以高，是因為投資者認為這種糟糕的收入表現將會好轉。如果沒有，那麼現有股東可能會對股價的可行性感到極度緊張。</p>
<p>如果您想了解分析師對未來的預測，您應該查看我們關於 EyePoint 的 <strong>免費</strong> 報告。</p>
<h2>收入預測是否與高市銷率相匹配？</h2>
<p>EyePoint 的市銷率對於一家預計將實現非常強勁增長的公司來説是典型的，重要的是，其表現將遠超行業水平。</p>
<p>回顧過去一年，該公司的收入出現了令人沮喪的 7.4% 的下降。這抹去了過去三年中的任何增長，總體上幾乎沒有實現收入的變化。因此，可以公平地説，該公司的收入增長最近一直不穩定。</p>
<p>展望未來，預計未來三年將實現每年 72% 的增長，這是由觀察該公司的十二位分析師估算的。這一增長預計將顯著高於更廣泛行業的 28% 的年增長率。</p>
<p>考慮到這一點，理解為什麼 EyePoint 的市銷率相對於其行業同行如此之高並不困難。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
<h2>關鍵要點</h2>
<p>強勁的股價飆升導致 EyePoint 的市銷率也隨之飆升。通常情況下，我們會警惕在做出投資決策時過度解讀市銷率，儘管它可以揭示其他市場參與者對公司的看法。</p>
<p>我們對 EyePoint 的分析顯示，其市銷率仍然高於其強勁的未來收入的合理性。股東們似乎對公司的未來收入充滿信心，這支撐了市銷率。除非這些條件發生變化，否則它們將繼續為股價提供強有力的支持。</p>
<p>在您採取下一步之前，您應該瞭解我們發現的 <strong>EyePoint 的 3 個警告信號</strong>。</p>
<p>當然，<strong>盈利能力強且有良好盈利增長曆史的公司通常是更安全的投資</strong>。因此，您可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司具有合理的市盈率並且盈利增長強勁。</p>
<p>國防與災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的。它是完全自主的塔樓，在 30 分鐘內提供 5G、ISR 和雷達服務，隨時隨地。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>由 CiTech 贊助</p>

EYPT

<p>EyePoint, Inc.（納斯達克代碼：EYPT）的股價最近上漲了 38%，使其在過去一年中上漲了 103%。儘管其市銷率為 31.5 倍，遠高於行業同行，但投資者對未來增長持樂觀態度，預計未來三年年均增長將達到 72%。這種樂觀情緒支撐了當前的股價，儘管最近收入有所下降。分析師建議保持謹慎，指出高市銷率反映了對未來收入的強烈預期</p>

<p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) shareholders would be excited to see that the share price has had a great month, posting a 38% gain and recovering from prior weakness. The last month tops off a massive increase of 103% in the last year.</p>
<div class="lb-trans"><p><strong>EyePoint, Inc.</strong> (NASDAQ:EYPT) 的股東們會很高興地看到，股價在過去一個月表現出色，上漲了 38%，並從之前的疲軟中恢復過來。上個月的表現為過去一年 103% 的大幅增長畫上了句號。</p>
</div><p>Following the firm bounce in price, EyePoint's price-to-sales (or &#34;P/S&#34;) ratio of 31.5x might make it look like a strong sell right now compared to other companies in the Pharmaceuticals industry in the United States, where around half of the companies have P/S ratios below 4.1x and even P/S below 1.3x are quite common. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>在價格大幅反彈後，EyePoint 的市銷率（&#34;P/S&#34;）為 31.5 倍，與美國製藥行業的其他公司相比，可能看起來像是一個強烈的賣出信號，因為大約一半的公司市銷率低於 4.1 倍，甚至低於 1.3 倍的市銷率也相當普遍。不過，僅僅將市銷率表面化是不明智的，因為可能有解釋説明其如此高的原因。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承諾要&#34;釋放&#34;美國的石油和天然氣，這 15 只美國股票的發展有望受益。</p>
</div><p>Check out our latest analysis for EyePoint</p>
<div class="lb-trans"><p>查看我們對 EyePoint 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809" alt="" original-src="https://images.simplywall.st/asset/chart/4481199-ps-multiple-vs-industry-1-dark-2/1765563441809"/></p>
<p>NasdaqGM:EYPT Price to Sales Ratio vs Industry December 12th 2025</p>
<div class="lb-trans"><p>NasdaqGM:EYPT 市銷率與行業比較 2025 年 12 月 12 日</p>
</div><h3>What Does EyePoint's P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>EyePoint 的市銷率對股東意味着什麼？</h3>
</div><p>EyePoint hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. One possibility is that the P/S ratio is high because investors think this poor revenue performance will turn the corner. If not, then existing shareholders may be extremely nervous about the viability of the share price.</p>
<div class="lb-trans"><p>最近，EyePoint 的表現不佳，其收入下降與其他公司相比顯得相當糟糕，後者的收入平均有所增長。一個可能性是，市銷率之所以高，是因為投資者認為這種糟糕的收入表現將會好轉。如果沒有，那麼現有股東可能會對股價的可行性感到極度緊張。</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on EyePoint.</p>
<div class="lb-trans"><p>如果您想了解分析師對未來的預測，您應該查看我們關於 EyePoint 的 <strong>免費</strong> 報告。</p>
</div><h2>Do Revenue Forecasts Match The High P/S Ratio?</h2>
<div class="lb-trans"><h2>收入預測是否與高市銷率相匹配？</h2>
</div><p>EyePoint's P/S ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the industry.</p>
<div class="lb-trans"><p>EyePoint 的市銷率對於一家預計將實現非常強勁增長的公司來説是典型的，重要的是，其表現將遠超行業水平。</p>
</div><p>Retrospectively, the last year delivered a frustrating 7.4% decrease to the company's top line. This has erased any of its gains during the last three years, with practically no change in revenue being achieved in total. Therefore, it's fair to say that revenue growth has been inconsistent recently for the company.</p>
<div class="lb-trans"><p>回顧過去一年，該公司的收入出現了令人沮喪的 7.4% 的下降。這抹去了過去三年中的任何增長，總體上幾乎沒有實現收入的變化。因此，可以公平地説，該公司的收入增長最近一直不穩定。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 72% per annum as estimated by the twelve analysts watching the company. That's shaping up to be materially higher than the 28% per annum growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未來，預計未來三年將實現每年 72% 的增長，這是由觀察該公司的十二位分析師估算的。這一增長預計將顯著高於更廣泛行業的 28% 的年增長率。</p>
</div><p>With this in mind, it's not hard to understand why EyePoint's P/S is high relative to its industry peers. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>考慮到這一點，理解為什麼 EyePoint 的市銷率相對於其行業同行如此之高並不困難。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><p>The strong share price surge has lead to EyePoint's P/S soaring as well. Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.</p>
<div class="lb-trans"><p>強勁的股價飆升導致 EyePoint 的市銷率也隨之飆升。通常情況下，我們會警惕在做出投資決策時過度解讀市銷率，儘管它可以揭示其他市場參與者對公司的看法。</p>
</div><p>Our look into EyePoint shows that its P/S ratio remains high on the merit of its strong future revenues. It appears that shareholders are confident in the company's future revenues, which is propping up the P/S. Unless these conditions change, they will continue to provide strong support to the share price.</p>
<div class="lb-trans"><p>我們對 EyePoint 的分析顯示，其市銷率仍然高於其強勁的未來收入的合理性。股東們似乎對公司的未來收入充滿信心，這支撐了市銷率。除非這些條件發生變化，否則它們將繼續為股價提供強有力的支持。</p>
</div><p>Before you take the next step, you should know about the <strong>3 warning signs for EyePoint</strong> that we have uncovered.</p>
<div class="lb-trans"><p>在您採取下一步之前，您應該瞭解我們發現的 <strong>EyePoint 的 3 個警告信號</strong>。</p>
</div><p>Of course, <strong>profitable companies with a history of great earnings growth are generally safer bets</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>當然，<strong>盈利能力強且有良好盈利增長曆史的公司通常是更安全的投資</strong>。因此，您可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司具有合理的市盈率並且盈利增長強勁。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>國防與災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的。它是完全自主的塔樓，在 30 分鐘內提供 5G、ISR 和雷達服務，隨時隨地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 贊助</p>
</div>

EyePoint 公司（NASDAQ:EYPT）的股票在上漲 38% 後並未被市場忽視